Bio-View Ltd BIOV.TA Stock
Bio-View Ltd Price Chart
Bio-View Ltd BIOV.TA Financial and Trading Overview
Bio-View Ltd stock price | 28.2 ILA |
Previous Close | 350.9 ILA |
Open | 352.9 ILA |
Bid | 352 ILA x 13300 |
Ask | 356.2 ILA x 648400 |
Day's Range | 335 - 352.9 ILA |
52 Week Range | 302 - 480 ILA |
Volume | 1.75K ILA |
Avg. Volume | 9.16K ILA |
Market Cap | 47.74M ILA |
Beta (5Y Monthly) | 0.548972 |
PE Ratio (TTM) | 68.659996 |
EPS (TTM) | 0 ILA |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | March 22, 2017 |
1y Target Est | N/A |
BIOV.TA Valuation Measures
Enterprise Value | 32.02M ILA |
Trailing P/E | 68.659996 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.6380751 |
Price/Book (mrq) | 168.0372 |
Enterprise Value/Revenue | 1.099 |
Enterprise Value/EBITDA | 88.214 |
Trading Information
Bio-View Ltd Stock Price History
Beta (5Y Monthly) | 0.548972 |
52-Week Change | -8.37% |
S&P500 52-Week Change | 20.43% |
52 Week High | 480 ILA |
52 Week Low | 302 ILA |
50-Day Moving Average | 359.46 ILA |
200-Day Moving Average | 373.82 ILA |
BIOV.TA Share Statistics
Avg. Volume (3 month) | 9.16K ILA |
Avg. Daily Volume (10-Days) | 4.29K ILA |
Shares Outstanding | 13.57M |
Float | 5.83M |
Short Ratio | N/A |
% Held by Insiders | 63.93% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.01% |
Operating Margin (ttm) | 0.35% |
Gross Margin | 57.19% |
EBITDA Margin | 1.24% |
Management Effectiveness
Return on Assets (ttm) | 0.15% |
Return on Equity (ttm) | 2.11% |
Income Statement
Revenue (ttm) | 29.15M ILA |
Revenue Per Share (ttm) | 2.1 ILA |
Quarterly Revenue Growth (yoy) | 0.70% |
Gross Profit (ttm) | 16.67M ILA |
EBITDA | 363K ILA |
Net Income Avi to Common (ttm) | 587K ILA |
Diluted EPS (ttm) | 0.05 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 19.44M ILA |
Total Cash Per Share (mrq) | 1.4 ILA |
Total Debt (mrq) | 4.06M ILA |
Total Debt/Equity (mrq) | 14.35 ILA |
Current Ratio (mrq) | 3.114 |
Book Value Per Share (mrq) | 2.043 |
Cash Flow Statement
Operating Cash Flow (ttm) | 968K ILA |
Levered Free Cash Flow (ttm) | 510.88K ILA |
Profile of Bio-View Ltd
Country | Israel |
State | N/A |
City | Rehovot |
Address | 3 Pekeris Street |
ZIP | 7670203 |
Phone | 972 73 227 1025 |
Website | https://www.bioview.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 34 |
Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. Its products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; Solo Touch Workstation, a stand-alone workstation with advanced review and analysis tools; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd has a partnership agreement with ANGLE plc to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 2000 and is headquartered in Rehovot, Israel.
Q&A For Bio-View Ltd Stock
What is a current BIOV.TA stock price?
Bio-View Ltd BIOV.TA stock price today per share is 28.2 ILA.
How to purchase Bio-View Ltd stock?
You can buy BIOV.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bio-View Ltd?
The stock symbol or ticker of Bio-View Ltd is BIOV.TA.
Which industry does the Bio-View Ltd company belong to?
The Bio-View Ltd industry is Medical Devices.
How many shares does Bio-View Ltd have in circulation?
The max supply of Bio-View Ltd shares is 1.36M.
What is Bio-View Ltd Price to Earnings Ratio (PE Ratio)?
Bio-View Ltd PE Ratio is now.
What was Bio-View Ltd earnings per share over the trailing 12 months (TTM)?
Bio-View Ltd EPS is 0 ILA over the trailing 12 months.
Which sector does the Bio-View Ltd company belong to?
The Bio-View Ltd sector is Healthcare.